F-24 (National Institute of Pharmaceutical Education and Research)

N/A

Report date: 2025/01/26 18:00:39
NME

Base Information

Drug NameF-24 (National Institute of Pharmaceutical Education and Research)
Drug Alias Namecholinesterase inhibitors (National Institute of Pharmaceutical Education and Research)EJMC-7A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCholinesterase inhibitors
TargetsCholinesterase
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNational Institute of Pharmaceutical Education and Research SAS
China Registration ClassN/A

Develop Information

Active CompaniesNational Institute of Pharmaceutical Education and Research SAS
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A